β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal...
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells
About this item
Full title
Author / Creator
Miele, Evelina , Po, Agnese , Begalli, Federica , Antonucci, Laura , Mastronuzzi, Angela , Marras, Carlo Efisio , Carai, Andrea , Cucchi, Danilo , Abballe, Luana , Besharat, Zein Mersini , Catanzaro, Giuseppina , Infante, Paola , Di Marcotullio, Lucia , Canettieri, Gianluca , De Smaele, Enrico , Screpanti, Isabella , Locatelli, Franco and Ferretti, Elisabetta
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
Aberrant Sonic Hedgehog/Gli (Hh/Gli) signaling pathway is a critical regulator of Sonic hedgehog medulloblastoma (SHH-MB). Cancer stem cells (CSCs), thought to be largely responsible for tumor initiation, maintenance, dissemination and relapse, have been identified in SHH-MB. Since we previously demonstrated that Hh/Gli signaling controls CSCs feat...
Alternative Titles
Full title
β-arrestin1-mediated acetylation of Gli1 regulates Hedgehog/Gli signaling and modulates self-renewal of SHH medulloblastoma cancer stem cells
Authors, Artists and Contributors
Author / Creator
Po, Agnese
Begalli, Federica
Antonucci, Laura
Mastronuzzi, Angela
Marras, Carlo Efisio
Carai, Andrea
Cucchi, Danilo
Abballe, Luana
Besharat, Zein Mersini
Catanzaro, Giuseppina
Infante, Paola
Di Marcotullio, Lucia
Canettieri, Gianluca
De Smaele, Enrico
Screpanti, Isabella
Locatelli, Franco
Ferretti, Elisabetta
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b6b1f6c9e3fc447a83388b129c8c3c64
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b6b1f6c9e3fc447a83388b129c8c3c64
Other Identifiers
ISSN
1471-2407
E-ISSN
1471-2407
DOI
10.1186/s12885-017-3477-0